Your browser doesn't support javascript.
loading
SARS-CoV-2 outbreak in a nursing home after vaccination with BNT162b2: A role for the quantification of circulating antibodies.
Càmara, Jordi; González-Díaz, Aida; Barrabeig, Irene; Fernández-Huerta, Miguel; Calatayud, Laura; Niubó, Jordi; Martí, Sara; Ángeles Domínguez, Ma; Ardanuy, Carmen.
Afiliação
  • Càmara J; Microbiology Department, Hospital Universitari Bellvitge, University of Barcelona-IDIBELL, L'Hospitalet de Llobregat, Spain; CIBER de Enfermedades Respiratorias (CIBERes), ISCIII, Madrid, Spain. Electronic address: jcamara@bellvitgehospital.cat.
  • González-Díaz A; Microbiology Department, Hospital Universitari Bellvitge, University of Barcelona-IDIBELL, L'Hospitalet de Llobregat, Spain; CIBER de Enfermedades Respiratorias (CIBERes), ISCIII, Madrid, Spain.
  • Barrabeig I; Epidemiological Surveillance and Response to Public Health Emergencies Unit in Barcelona South. Agency of Public Health of Catalonia, Generalitat of Catalonia, Spain; CIBER de Epidemiología y Salud Pública (CIBEResp), ISCIII, Madrid, Spain.
  • Fernández-Huerta M; Microbiology Department, Hospital Universitari Bellvitge, University of Barcelona-IDIBELL, L'Hospitalet de Llobregat, Spain.
  • Calatayud L; Microbiology Department, Hospital Universitari Bellvitge, University of Barcelona-IDIBELL, L'Hospitalet de Llobregat, Spain; CIBER de Enfermedades Respiratorias (CIBERes), ISCIII, Madrid, Spain.
  • Niubó J; Microbiology Department, Hospital Universitari Bellvitge, University of Barcelona-IDIBELL, L'Hospitalet de Llobregat, Spain.
  • Martí S; Microbiology Department, Hospital Universitari Bellvitge, University of Barcelona-IDIBELL, L'Hospitalet de Llobregat, Spain; CIBER de Enfermedades Respiratorias (CIBERes), ISCIII, Madrid, Spain.
  • Ángeles Domínguez M; Microbiology Department, Hospital Universitari Bellvitge, University of Barcelona-IDIBELL, L'Hospitalet de Llobregat, Spain; CIBER de Enfermedades Infecciosas (CIBERinfec), ISCIII, Madrid, Spain; Departament of Pathology and Experimental Therapeutics, University of Barcelona, Barcelona, Spain.
  • Ardanuy C; Microbiology Department, Hospital Universitari Bellvitge, University of Barcelona-IDIBELL, L'Hospitalet de Llobregat, Spain; CIBER de Enfermedades Respiratorias (CIBERes), ISCIII, Madrid, Spain; Departament of Pathology and Experimental Therapeutics, University of Barcelona, Barcelona, Spain.
Vaccine ; 40(18): 2531-2534, 2022 04 20.
Article em En | MEDLINE | ID: mdl-35307228
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article